PMH7 OUTCOMES AND COST OF TREATMENT WITH RISPERIDONE VERSUS OLANZAPINE AMONG PATIENTS WITH CHRONIC SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS
Abstract
Authors
M Vera-Llonch G Oster T Delea M Rupnow A Grogg
M Vera-Llonch G Oster T Delea M Rupnow A Grogg
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now